BIOMAT Database Logo BIOMAT Database Logo

Maintenance ECT in intractable manic-depressive disorders. 1994

J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
Service Hospitalo Universitaire de Santé Mentale et de Thérapeutique, Paris V René Descartes University, France.

Twenty-two patients suffering from intractable recurrent unipolar or bipolar mood disorders were enrolled in a maintenance-ECT protocol (ECT-M) for more than 18 months, with a treatment at approximately monthly intervals. Eleven have continued treatment for > 2 years. Whereas 44% of the year had been spent in the hospital with at least three episodes a year prior to ECT-M, only 7% of the year was spent in the hospital during ECT-M with only one relapse every 16 months requiring admission (p < 0.001). Forty-five percent of the patients were in full remission and 27% in partial remission according to DSM-III-R criteria. ECT-M responsiveness of rapid-cyclers and delusional depressed patients usually drug refractory has been very encouraging with full or partial remission for 100% of rapid-cyclers and 80% of delusional depressed patients.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010359 Patient Readmission Subsequent admissions of a patient to a hospital or other health care institution for treatment. Hospital Readmission,Rehospitalization,Unplanned Hospital Readmissions,Unplanned Readmission,30 Day Readmission,Hospital Readmissions,Readmission, Hospital,Readmissions, Hospital,Thirty Day Readmission,30 Day Readmissions,Hospital Readmission, Unplanned,Hospital Readmissions, Unplanned,Readmission, Patient,Readmission, Thirty Day,Readmission, Unplanned,Rehospitalizations,Thirty Day Readmissions,Unplanned Hospital Readmission,Unplanned Readmissions
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003702 Delusions A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates. Delusion
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions

Related Publications

J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
[Carbamazepine in manic-depressive disorders].
November 1986, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
Effects of treatment latency on response to maintenance treatment in manic-depressive disorders.
June 2007, Bipolar disorders,
J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
Maintenance ECT and Affective Disorders.
January 1987, Convulsive therapy,
J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
[Depression and manic-depressive disorders].
April 1999, La Revue du praticien,
J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
[Manic-depressive disorders. Current concepts].
January 1997, Soins. Psychiatrie,
J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
Thyroid hormones in manic-depressive disorders.
April 1983, The American journal of psychiatry,
J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
[Manic-depressive disorders. Bipolar disorders. Case reports].
January 1997, Soins. Psychiatrie,
J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
Recurrence risk in bipolar manic-depressive disorders after discontinuing lithium maintenance treatment: an overview.
January 1998, Clinical drug investigation,
J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
[Drug therapy of manic-depressive disorders].
May 1994, Nihon rinsho. Japanese journal of clinical medicine,
J M Vanelle, and H Loo, and A Galinowski, and W de Carvalho, and M C Bourdel, and P Brochier, and O Bouvet, and T Brochier, and J P Olie
[Biochemical approach to manic-depressive disorders].
May 1973, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
Copied contents to your clipboard!